个体保险状态与医院支付方构成对宫颈癌女性生存的相对重要性
基于美国国家癌症数据库2004至2017年124,339例宫颈癌患者数据,评估个体保险状态与医院支付方构成(安全网医院)对诊疗质量和生存的相对贡献。结果显示诊疗质量在各医院四分位组间无显著差异,在安全网医院治疗死亡风险较Q1医院高14%(HR=1.14;95%CL,1.08-1.20),无保险者较私人保险者死亡风险高32%(HR=1.32;95%CI,1.26-1.38),医疗补助者高40%(HR=1.40;95%CI,1.35-1.44),同时纳入两者时仅个体保险状态保留显著影响。结论认为个体保险可能是比就医地点和医院支付方构成更重要的生存预测因素。
要点
- 安全网医院治疗者死亡风险较Q1医院高14%(HR=1.14;95%CL,1.08-1.20)。
- 无保险者死亡风险较私人保险者高32%(HR=1.32;95%CI,1.26-1.38)。
- 医疗补助者死亡风险较私人保险者高40%(HR=1.40;95%CI,1.35-1.44)。
核心结论
- 个体保险可能是比就医地点和医院支付方构成更重要的宫颈癌女性生存预测因素。
- 无论医院支付方构成如何,医院内基于个体保险的结局存在实质性差异。
研究设计与样本
- 使用美国国家癌症数据库识别2004至2017年诊断的宫颈癌患者。
- 按保险状态(无保险/医疗补助/私人保险/医疗保险/其他)分类患者,并按无保险/医疗补助患者比例四分位分组医院(最高四分位定义为安全网医院,最低为Q1医院)。
- 共纳入124,339例患者,其中无保险11,338例(9.1%)、医疗补助27,281例(21.9%),就诊于1156家医院。
- 以循证指标依从性评估诊疗质量,采用比例风险Cox模型评估保险状态和支付方构成对生存的个体贡献。
主要发现
- 诊疗质量在各医院四分位组间无显著差异。
- 调整患者临床/人口学特征后,安全网医院治疗者死亡风险较Q1医院高14%(HR=1.14;95%CL,1.08-1.20)。
- 无保险者死亡风险较私人保险者高32%(HR=1.32;95%CI,1.26-1.38)。
- 医疗补助者死亡风险较私人保险者高40%(HR=1.40;95%CI,1.35-1.44)。
- 同时考察支付方构成和保险状态时,仅个体保险状态对死亡率保留显著影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the relative contributions of individual insurance status and hospital payer mix (safety net status) to quality of care and survival for patients with cervical cancer. METHODS: We used the National Cancer Database to identify patients with cervical cancer diagnosed from 2004 to 2017. Patients were classified by insurance (uninsured/Medicaid/private/Medicare/other) and hospitals were grouped into quartiles based on the proportion of uninsured/Medicaid patients (payer mix) (top quartile defined as safety-net hospital (SNHs) and lowest as Q1 hospitals). Quality-of-care was assessed by adherence to evidence-based metrics. Individual contributions of insurance status and payer mix to survival was assessed with a proportional hazards Cox model. RESULTS: A total of 124,339 patients including 11,338 uninsured (9.1%) and 27,281 Medicaid (21.9%) recipients treated at 1156 hospitals were identified. Quality-of-care was not significantly different across hospital quartiles. Adjusting for patients' clinical/demographic characteristics, treatment at a SNH was associated with a 14% higher mortality (HR = 1.14; 95% CL, 1.08-1.20) than at Q1 hospitals. Testing for individual insurance, uninsured patients had 32% increased mortality (HR = 1.32; 95% CI,1.26-1.38) and Medicaid recipients 40% increased (HR = 1.40; 95%CI,1.35-1.44) compared to privately insured patients. Examining both payer mix and insurance, only individual insurance retained a significant impact on mortality. CONCLUSIONS: Individual insurance may be a more important predictor of survival than site-of-care and hospital payer mix for women with cervical cancer. There is substantial variation in outcomes within hospitals based on individual insurance, regardless of hospital payer mix.
引用
- Cherston C, Yoh K, Huang Y, et al. Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer. Gynecol Oncol. 2022. PMID: 35787803. doi:10.1016/j.ygyno.2022.06.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。